Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia (Q37800310)

23 August 2017

0 references

Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia (English)

1 reference

methicillin-resistant Staphylococcus aureus

23 August 2017

main subject

0 references

antibiotic resistance

1 reference

based on heuristic

inferred from title

Staphylococcus aureus

1 reference

10

Leonard Leibovici

1 reference

23 August 2017

1

Mical Paul

1 reference

23 August 2017

3

Elad Goldberg

1 reference

23 August 2017

9

Jihad Bishara

1 reference

23 August 2017

7

Zmira Samra

1 reference

23 August 2017

6

Rawi Hazzan

1 reference

23 August 2017

2

Galia Kariv

1 reference

23 August 2017

5

Hila Shaked

1 reference

23 August 2017

Maria Raskin

4

1 reference

23 August 2017

Dina Paghis

series ordinal

8

1 reference

23 August 2017

language of work or name

English

0 references

publication date

14 October 2010

1 reference

Journal of Antimicrobial Chemotherapy

23 August 2017

published in

1 reference

23 August 2017

volume

65

1 reference

23 August 2017

issue

12

1 reference

23 August 2017

page(s)

2658-2665

1 reference

NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Comparative evaluation of epidemiology and outcomes of methicillin-resistant Staphylococcus aureus (MRSA) USA300 infections causing community- and healthcare-associated infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: impact on the outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Predictors of mortality in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: the role of empiric antibiotic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Impact of inappropriate empirical therapy for sepsis due to health care-associated methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Methicillin-resistant Staphylococcus aureus sterile-site infection: The importance of appropriate initial antimicrobial treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Comment on guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

A review of two journals found that articles using multivariable logistic regression frequently did not report commonly recommended assumptions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Outcome of inappropriate empirical antibiotic therapy in patients with Staphylococcus aureus bacteraemia: analytical strategy using propensity scores

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Delay of active antimicrobial therapy and mortality among patients with bacteremia: impact of severe neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Time to blood culture positivity as a predictor of clinical outcome of Staphylococcus aureus bloodstream infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Clinical consensus conference: survey on Gram-positive bloodstream infections with a focus on Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Empiric antibiotic therapy for Staphylococcus aureus bacteremia may not reduce in-hospital mortality: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Relationship of vancomycin minimum inhibitory concentration to mortality in patients with methicillin-resistant Staphylococcus aureus hospital-acquired, ventilator-associated, or health-care-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: mortality analyses and the impact of vancomycin, MIC = 2 mg/L, by the broth microdilution method

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Effect of vancomycin plus rifampicin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

The role of vancomycin in the persistence or recurrence of Staphylococcus aureus bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

Prediction of specific pathogens in patients with sepsis: evaluation of TREAT, a computerized decision support system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ373

21 January 2018

Identifiers

DOI

10.1093/JAC/DKQ373

1 reference

23 August 2017

1 reference